| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
2e-08 |
| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
3e-07 |
| mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
2e-06 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
4e-06 |
| mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
7e-06 |
| mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0001 |
| mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0002 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0002 |